GMDA News and Press, Gamida Cell Ltd. From 04/17/23

2023-04-17 15:24:51 ET Thanks to an explosion of interest in penny stocks , plenty of stocks under $5 are gaining momentum in the stock market today. Whether you’re looking for short squeeze stocks, low float stocks, or simply hunting for a list of penny stocks in a specific sect...

2023-04-17 13:51:18 ET The US FDA has approved Omisirge (omidubicel-onlv), an  allogeneic blood-based cell therapy from Gamida Cell Ltd. ( NASDAQ: GMDA ) for patients with blood cancers to be used before umbilical cord blood transplants. The stock is up 34% i...

2023-03-27 13:06:40 ET Gainers: WiSA Technologies ( WISA ) +93% . First Citizens BancShares ( FCNCA ) +50% . Alimera Sciences ( ALIM ) +38% . Cimpress ( CMPR ) +30% . Gorilla Technology Group ( GRRR ) +25% . CBL International...

2023-03-27 12:30:13 ET Gamida Cell ( NASDAQ: GMDA ) is trading around -25% on Monday after it said at the end of its 2022 results it expects current cash and cash equivalents to support operations through Q3 2023. Net loss for 2022 was $79.4M and EPS missed analysts' est...

2023-03-27 12:25:04 ET Gamida Cell Ltd. (GMDA) Q4 2023 Earnings Conference Call March 27, 2023, 8:00 AM ET Company Participants Abigail Jenkins - President and Chief Executive Officer Ronit Simantov - Chief Medical and Chief Scientific Officer Michele Korfin - Ch...

2023-03-27 07:03:02 ET Gamida Cell press release ( NASDAQ: GMDA ): FY GAAP EPS of -$1.24 misses by $0.05 . Gamida Cell expects its current cash and cash equivalents of $64.7M will support the company’s ongoing operating activities through the third quarter of 20...

Company reports on productive interactions with FDA and preparations for launch of omidubicel, if approved, in advance of May 1 PDUFA date Company outlines strategic restructuring, plans to prioritize omidubicel launch and reduce operating expenses to extend cash runway Co...

2023-03-24 10:46:41 ET Gamida Cell ( NASDAQ: GMDA ) is scheduled to announce FY earnings results on Monday, March 27th, before market open. The consensus EPS Estimate is -$1.19 (+21.7% Y/Y) Over the last 1 year, GMDA has beaten EPS estimates 25% of the time and has...

2023-03-20 17:58:46 ET Gamida Cell ( NASDAQ: GMDA ) on Monday announced the resignation of chairman Robert Blum and the appointment of Shawn Cline Tomasello as chairwoman, effective immediately. Tomasello joined Gamida Cell’s board in June 2019. ...

Shawn Cline Tomasello to become Chairwoman, succeeding Chairman Robert I. Blum, who is resigning; Company focuses on upcoming regulatory milestone and commercialization Directors Dr. Naama Halevi-Davidov and Dr. Anat Cohen-Dayag also stepping down Gamida Cell Ltd. (Nasdaq: G...